Data / Form D filings / Adimab, Inc.
Adimab, Inc.: Form D filings
Adimab, Inc., a biotechnology company in Lebanon, NH, filed 2 Form D notices with the SEC between 2009 and 2010. The latest, on November 29, 2010, reports $4 million sold of a $4 million offering to 10 investors.
Find out what Adimab, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 16 Cavendish Court, Lebanon, NH, 03766
- Phone
- (603) 727-7107
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2007
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1407166
The full lists. Form D filings in New Hampshire: 127 rows, $6.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 29, 2010 | New notice | $3,999,909 | $3,999,909 | $0 | 10 | Nov 22, 2010 | sec.gov |
| Oct 6, 2009 | New notice | $8,205,751 | $8,205,751 | $0 | 10 | Sep 22, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert L. Birnbaum | Executive Officer | |
| Tillman U. Gerngross | Executive Officer, Director | |
| William J. Maris | Director | |
| Terrance L. McGuire | Director | |
| Michael L. Ross | Director | |
| Errik B. Anderson | Executive Officer |
Every Form D from the week of Nov 29, 2010 · All recent filings in New Hampshire · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Adimab, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.